25 Years of Navitas Industry Networks Through 25 Voices of Peer Leadership

25 Years in 25 Voices of Peer Leadership

For 25 years, the forums and peer networks powered by Navitas Life Sciences have brought together pharmaceutical, biotech, pharmacovigilance and regulatory leaders to exchange ideas, solve complex challenges and support the growth of the life sciences industry.

In an industry defined by rapid transformation, changing regulations, AI-enabled operations and increasing global complexity, a sole constant is the importance of meaningful professional networking and peer collaboration.

From pharmacovigilance forums and regulatory affairs discussions to labeling roundtables and medical writing conversations, these industry gatherings have become trusted platforms for pharmaceutical professionals seeking real-world insight, benchmarking opportunities and collaborative problem-solving.

As we celebrate 25 Voices. 25 Years., we look back at the conversations, insights and experiences that have made these forums one of the most valued networking and knowledge-sharing communities in life sciences.

Why Pharma Networking Matters in 2026

The pharmaceutical and life sciences industry continues to grow with multiple changes being incorporated including:

• AI-driven pharmacovigilance transformation
• Increasing regulatory complexity
• Global labeling harmonization
• Digital transformation in clinical operations
• Real-world evidence and data modernization
• Operational efficiency pressures
• Cross-functional collaboration challenges

In this environment, pharmaceutical industry networking is essential.

The most successful organizations are those that actively engage with peers, share experiences openly and learn collaboratively from industry experts facing similar challenges.

Over the years, Navitas Life Sciences forums have created exactly that environment: a trusted space where professionals across pharma, biotech and life sciences can exchange ideas, benchmark strategies and discuss the future of the industry together.

One attendee summarized the value perfectly:

“This is really EXCELLENT data, Thank you so much! I believe this is the kind of insight that demonstrates the value of the PVNet benchmark.” - Head of Strategic Business Planning & Execution, Top 10 global Pharma Company.

“The May meeting was certainly one of the best regulatory events I've attended …… we will be happy to participate in any other events you host” - Top 10 global Pharma Company

Building One of the Industry’s Most Trusted Pharma Networking Communities

What began as focused peer-to-peer discussions has evolved into a respected pharmaceutical leadership and networking platform connecting professionals across pharmacovigilance, regulatory affairs, labeling, safety, quality and medical writing.

Unlike traditional conferences, these forums emphasize interaction, collaboration and practical application over passive presentations.

Participants consistently highlight the value of engaging directly with peers and industry experts.

“The event was a nice balance of overview information coupled with real industry experience and further supplemented with broader group discussions.”
• Associate Director, Global Labeling, Top 20 Pharmaceutical Company

“Thank you for an engaging forum!”
• Senior Director, Global Labeling

“Many thanks for hosting and facilitating the forums, very beneficial and much appreciated!”
• Head of Global Labeling Content

“I really enjoyed joining the forum and the way in which it was conducted. Presentations and discussions were of a good level.”
• Networks Member

“The last presentation was fascinating! Thank you to you and your team for all of your hard work in putting this together.”
• Networks Member

The forums have become recognized spaces for:

• Pharmaceutical networking and collaboration
• Regulatory intelligence sharing
• Pharmacovigilance best practice discussions
• Industry benchmarking
• Clinical and safety operations conversations
• Global regulatory updates
• Labeling strategy discussions
• AI and digital transformation dialogue
• Cross-functional life sciences collaboration

These conversations continue to help pharmaceutical professionals manage change while building meaningful professional relationships across the industry.

Real Industry Conversations with Real Business Impact

One reason these pharma networking forums continue to resonate after 25 years is their strong focus on practical insight and operational relevance.

Participants consistently point to case studies, peer learning and use-case driven discussions as the most valuable aspects of the experience.

“The case studies were the biggest highlight of the forums!”
• Networks Member

“Excellent topics and was able to gain a lot of new information which will be applied to my work.”
• Global QPPV

“Use case talks are always of high-value. Having both technical and operational people on hand for Q&A always makes them even better.”
• Director of Safety Systems

“One of the best forums so far – intellectual discussions, very topical, high impact on industry.”
• Global PV Head

“Our experience with Navitas Networks confirms the membership provides a unique opportunity to uncover strategic and operational insights, which we then apply across our Global PV business, it is highly valuable in shaping our future PV direction”

- Head of PV operations, Top 5 Global Pharma company

In the current pharmaceutical landscape, organizations are increasingly seeking forums where they can discuss practical implementation challenges, operational strategies and emerging trends openly with peers.

These industry discussions provide help professionals gain actionable insights they can immediately apply within their own organizations.
• Networks Member

“Thank you, another great session of labelnet. The discussions are always enlightening!”

How Peer Networking Drives Innovation in Life Sciences

One of the defining strengths of successful pharmaceutical networking events is the ability to create authentic peer-to-peer engagement.

The best ideas often emerge not from formal presentations, but from conversations between professionals steering through similar operational realities.

That spirit of collaboration has remained central to these forums for 25 years.

“The breakouts were fun and allowed a greater opportunity to interact. I enjoyed hearing specifics about other companies. It was good to see/hear that our struggles are not unique.”
• Director of Labeling Strategy, Top 30 Pharmaceutical Company

“Another great discussion.”
• Networks Member

“Always great!”
• Networks Member

These interactions help create stronger professional communities while accelerating collective learning across the pharmaceutical ecosystem.

“Well chosen topics.”
• Networks Member

“Great speakers.”
• Networks Member

“Excellent moderation!”
• Networks Member

“Thank you for the great discussions and leadership.”
• Networks Member

As life sciences organizations increasingly adopt AI-enabled pharmacovigilance, automation and digital operating models, peer collaboration will continue to play a critical role in helping teams weave through such transformation successfully.

Global Regulatory and Pharmacovigilance Perspectives

As pharmaceutical operations become more globalized, cross-regional collaboration and regulatory intelligence sharing are becoming increasingly important.

The forums have consistently provided opportunities for global dialogue and multinational learning.

“Great facilitation, and very useful information about requirements in Japan and in China. I really enjoyed the open discussion.”
• Senior Medical Director, Global PV and QPPV

“It was very beneficial to have knowledgeable lawyers focused on PV to provide Regulatory information.”
• Global Head of Pharmacovigilance

These discussions help organizations better understand evolving global regulations, improve compliance readiness and strengthen cross-functional decision-making.

For many participants, the value lies not only in the presentations themselves, but in the ability to hear directly from peers across regions, functions and operating models.

The Human Side of Pharmaceutical Industry Collaboration

Technology, AI and automation are transforming life sciences at extraordinary speed but people remain at the center of industry progress.

Behind every regulatory breakthrough, operational improvement or innovation initiative are conversations, relationships and communities built on trust and shared expertise.

That human element continues to define these forums today.

One attendee reflected:

“Thanks again for inviting me to the face-to-face forum. The team did an outstanding job leading the discussions and drawing out the perspectives of each company representative in attendance.
It was very helpful to hear from peers across the industry regarding labeling functions’ organizational models, aspirations and challenges. There were many common themes, as well as some interesting new insights that I was able to take away from the day.”
• Head of Labeling, Advertising, and Promotion, Biotechnology Company

“The forum meetings and the gathering of peers is always a fantastic opportunity to network and gain insight, excellent leadership through the sessions – thank you”
• Global Head of pharmacovigilance, Top 10 Global Pharma Company

Over the last 25 years, these forums have demonstrated that the most impactful industry conversations happen when professionals engage openly and collaborate meaningfully.

Reimagining the Future of Life Sciences
Celebrating 25 Years of Industry Networks: landmark celebration at the iconic Carnegie Hall

For 25 years, the Navitas Life Sciences Networks have brought together some of the brightest minds across pharmaceuticals, biotechnology, pharmacovigilance, regulatory affairs, labeling and clinical development to challenge convention and exchange ideas.

Now, in a landmark celebration at the iconic Carnegie Hall, industry leaders, innovators and changemakers will come together for a milestone event unlike any before.

Reimagining the Future of Life Sciences is more than an anniversary gathering. It is a bold reflection on where the industry has been, where it is headed and how collaboration, innovation and peer leadership will define the next era of healthcare transformation.

 

At a time when AI-enabled operations, digital health ecosystems, evolving patient expectations and global regulatory shifts are rapidly reshaping the pharmaceutical landscape, the conversations happening in this room could not be more important.

This invitation-only executive event will convene senior leaders from across the life sciences ecosystem to explore the forces redefining the industry, from the future of labeling and pharmacovigilance to patient-centric innovation, emerging technologies and the next generation of operational excellence.

The agenda promises visionary perspectives and provocative dialogue from influential voices across the industry, including:

• Louise Jebson discussing the experiences shaping conversations behind the scenes

 

• Kyle Bryant bringing a powerful patient perspective on defining success in the future of healthcare

 

• Deborah Bebbington exploring how labeling may evolve in the next decade

 

• And many more….

For 25 years, these forums have sparked conversations that influenced strategy, inspired collaboration and strengthened industry-wide communities. This year’s event represents the next chapter in that journey, bringing together peer leaders not simply to discuss the future of life sciences.

From groundbreaking ideas to transformative insigts, from regulatory changes to human-centered innovation, this milestone gathering at Carnegie Hall will celebrate the power of industry networks to drive meaningful progress across global healthcare.

Because the future of life sciences will not be built in silos.
Twenty-five years. Twenty-five voices. Countless conversations continuing to shape the future of life sciences.

Learn more about our services and solutions by reaching out to us at This email address is being protected from spambots. You need JavaScript enabled to view it..